Literature DB >> 25439335

Contemporary medical management of peripheral arterial disease: a focus on risk reduction and symptom relief for intermittent claudication.

Kush Agrawal1, Robert T Eberhardt2.   

Abstract

Peripheral arterial disease (PAD) is primarily caused by progressive systemic atherosclerosis manifesting in the lower extremities. This review addresses the epidemiology, clinical presentation and evaluation, and medical management of PAD, with a focus on intermittent claudication. Key advances in the recognition of cardiovascular risk in asymptomatic individuals with mildly abnormal ankle-brachial index, newer reflections on exercise therapy, and a review of established and investigational agents for the treatment of symptomatic PAD, such as cilostazol, statins, and angiotensin-converting enzyme inhibitors, are highlighted.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ankle-brachial index; Atherosclerotic risk factors; Cilostazol; Intermittent claudication; Pentoxifylline; Peripheral arterial disease; Supervised exercise therapy

Mesh:

Substances:

Year:  2015        PMID: 25439335     DOI: 10.1016/j.ccl.2014.09.010

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  2 in total

1.  Factors Associated with Reinitiation of Statin Treatment in Older Patients with Peripheral Arterial Disease.

Authors:  Martin Wawruch; Gejza Wimmer; Jan Murin; Martina Paduchova; Tomas Tesar; Lubica Hlinkova; Peter Slavkovsky; Emma Aarnio
Journal:  Drugs Aging       Date:  2020-08       Impact factor: 3.923

2.  Non-Persistence With Antiplatelet Medications Among Older Patients With Peripheral Arterial Disease.

Authors:  Martin Wawruch; Jan Murin; Tomas Tesar; Martina Paduchova; Miriam Petrova; Denisa Celovska; Beata Havelkova; Michal Trnka; Emma Aarnio
Journal:  Front Pharmacol       Date:  2021-05-19       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.